SEI Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $126M | Buy |
2,286,880
+654,280
| +40% | +$35.5M | 0.12% | 184 |
|
|
2025
Q4 | $80.1M | Buy |
1,632,600
+717,769
| +78% | +$33.5M | 0.08% | 262 |
|
|
2025
Q3 | $39.5M | Buy |
914,831
+152,090
| +20% | +$5.94M | 0.04% | 455 |
|
|
2025
Q2 | $29.3M | Sell |
762,741
-331,338
| -30% | -$12.7M | 0.03% | 533 |
|
|
2025
Q1 | $42.4M | Buy |
1,094,079
+270,869
| +33% | +$9.92M | 0.05% | 376 |
|
|
2024
Q4 | $27.8M | Sell |
823,210
-122,138
| -13% | -$4.4M | 0.04% | 524 |
|
|
2024
Q3 | $38.6M | Buy |
945,348
+113,756
| +14% | +$4.65M | 0.05% | 399 |
|
|
2024
Q2 | $32M | Buy |
831,592
+24,658
| +3% | +$1.04M | 0.05% | 423 |
|
|
2024
Q1 | $34.6M | Buy |
806,934
+159,681
| +25% | +$6.59M | 0.05% | 405 |
|
|
2023
Q4 | $24M | Buy |
647,253
+13,723
| +2% | +$493K | 0.04% | 492 |
|
|
2023
Q3 | $23M | Sell |
633,530
-257,665
| -29% | -$9.15M | 0.04% | 480 |
|
|
2023
Q2 | $31.8M | Sell |
891,195
-20,277
| -2% | -$727K | 0.06% | 378 |
|
|
2023
Q1 | $32.4M | Buy |
911,472
+124,966
| +16% | +$4.37M | 0.06% | 356 |
|
|
2022
Q4 | $27.6M | Buy |
786,506
+247,398
| +46% | +$8.24M | 0.06% | 357 |
|
|
2022
Q3 | $15.9M | Buy |
539,108
+47,004
| +10% | +$1.78M | 0.04% | 555 |
|
|
2022
Q2 | $26.8M | Sell |
492,104
-9,502
| -2% | -$525K | 0.06% | 369 |
|
|
2022
Q1 | $27.3M | Sell |
501,606
-20,432
| -4% | -$1.11M | 0.06% | 372 |
|
|
2021
Q4 | $28.8M | Buy |
522,038
+36,856
| +8% | +$1.92M | 0.05% | 358 |
|
|
2021
Q3 | $23.2M | Buy |
485,182
+29,247
| +6% | +$1.47M | 0.05% | 396 |
|
|
2021
Q2 | $22.7M | Sell |
455,935
-53,067
| -10% | -$2.55M | 0.05% | 370 |
|
|
2021
Q1 | $22.7M | Buy |
509,002
+84,113
| +20% | +$3.82M | 0.06% | 339 |
|
|
2020
Q4 | $19.6M | Buy |
424,889
+17,667
| +4% | +$812K | 0.05% | 373 |
|
|
2020
Q3 | $19.2M | Buy |
407,222
+7,885
| +2% | +$395K | 0.06% | 321 |
|
|
2020
Q2 | $20.4M | Buy |
399,337
+12,877
| +3% | +$661K | 0.06% | 299 |
|
|
2020
Q1 | $18.3M | Sell |
386,460
-14,294
| -4% | -$762K | 0.07% | 280 |
|
|
2019
Q4 | $23.5M | Sell |
400,754
-1,012
| -0.3% | -$56.3K | 0.07% | 270 |
|
|
2019
Q3 | $34.2M | Buy |
401,766
+34,093
| +9% | +$1.75M | 0.09% | 208 |
|
|
2019
Q2 | $18.4M | Sell |
367,673
-2,857
| -0.8% | -$143K | 0.06% | 323 |
|
|
2019
Q1 | $19.3M | Sell |
370,530
-6,570
| -2% | -$328K | 0.07% | 304 |
|
|
2018
Q4 | $19M | Buy |
377,100
+451
| +0.1% | +$22.2K | 0.07% | 304 |
|
|
2018
Q3 | $18.9M | Sell |
376,649
-121,641
| -24% | -$6.18M | 0.07% | 288 |
|
|
2018
Q2 | $25.1M | Sell |
498,290
-31,537
| -6% | -$1.59M | 0.09% | 231 |
|
|
2018
Q1 | $25.9M | Buy |
529,827
+67,730
| +15% | +$3.15M | 0.1% | 204 |
|
|
2017
Q4 | $20.5M | Buy |
462,097
+192,847
| +72% | +$8.91M | 0.07% | 306 |
|
|
2017
Q3 | $13.7M | Buy |
269,250
+101,953
| +61% | +$5.17M | 0.05% | 455 |
|
|
2017
Q2 | $9.02M | Sell |
167,297
-6,539
| -4% | -$349K | 0.04% | 590 |
|
|
2017
Q1 | $9.16M | Buy |
173,836
+45,338
| +35% | +$2.3M | 0.04% | 548 |
|
|
2016
Q4 | $6.19M | Sell |
128,498
-13,802
| -10% | -$682K | 0.03% | 669 |
|
|
2016
Q3 | $7.67M | Buy |
142,300
+31,168
| +28% | +$1.71M | 0.04% | 528 |
|
|
2016
Q2 | $6.02M | Buy |
111,132
+55,686
| +100% | +$2.93M | 0.04% | 586 |
|
|
2016
Q1 | $2.81M | Buy |
55,446
+11,294
| +26% | +$563K | 0.02% | 836 |
|
|
2015
Q4 | $2.23M | Buy |
44,152
+11,159
| +34% | +$569K | 0.01% | 963 |
|
|
2015
Q3 | $1.58M | Sell |
32,993
-5,080
| -13% | -$264K | 0.01% | 885 |
|
|
2015
Q2 | $1.98M | Sell |
38,073
-162,764
| -81% | -$9.16M | 0.02% | 758 |
|
|
2015
Q1 | $11.6M | Buy |
200,837
+111,637
| +125% | +$6.4M | 0.1% | 240 |
|
|
2014
Q4 | $4.77M | Buy |
+89,200
| New | +$4.99M | 0.04% | 447 |
|
Other funds holding GSK
JEST
SEI Investments's GSK Position: Q1 2026 in Review
SEI Investments increased its GSK (GSK) stake by 40% in Q1 2026, buying an estimated $35.5M and bringing the position to 2,286,880 shares worth $126M. The position accounts for 0.12% of the portfolio, ranked #184.
SEI Investments first reported a position in GSK in Q4 2014 and has held it in 46 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- SEI Investments held 2,286,880 shares of GSK worth $126M as of Q1 2026.
- SEI Investments bought 654,280 GSK shares in Q1 2026, an estimated $35.5M.
- GSK made up 0.12% of SEI Investments's portfolio in Q1 2026, its #184 holding.
- SEI Investments first reported a position in GSK in Q4 2014 and has held it in 46 quarters since.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.